The Cannigma

OCTOBER 20, 2021

In 2020, Prohibition Partners stated that there are currently an estimated 3,000 patients receiving medical cannabis treatment in Switzerland. What Swiss law permits medical patients? With a medical cannabis permit, a patient can possess and use these medicines, and access them at participating pharmacies.

Legalization 52

Legalization Decriminalization Patients Medicine 52

The Joint Blog

FEBRUARY 24, 2021

Though trialing is relatively new and there is no clear scientific evidence as of yet, anecdotal evidence from patients is looking positive. They made it clear that no evidence is available and that there are real potential risks to treatment. had described some form of significant benefit from the treatment.

Treatment 55

Treatment Clinical Trials Collective Patients 55

SpeedWeed

APRIL 27, 2021

On Friday, lawmakers in the Montana Senate passed a bill establishing a framework for the nascent program, including a provision that “would reserve tax revenue from sales for addiction treatment and statewide conservation efforts,” according to the Associated Press. View original article.

Legalization 52

Legalization Programs Treatment Recreational 52

Veriheal

AUGUST 19, 2021

Roberts was simply offering up a perspective from the medical side and was not downplaying the importance and severity of implications for the patient. . The study also stated that scromiting is “an increasingly prevalent and complicated problem for health care providers and patients”. High Potency Products are a Recent Invention.

Consumption 96

Consumption Conditions Cannabis Patients 96

Canna Care Docs

NOVEMBER 23, 2020

Initiative 65 (74%) passed over the Alternative 65A (32%)—the latter of which would have restricted medicinal cannabis to terminally ill patients. Medicinal cannabis was already approved in Montana in 2004. Mississippi voters supported the less restrictive of two cannabis questions on the ballot.

Legalization 52

Legalization Medicine Conditions Recreational 52

The Cannigma

OCTOBER 9, 2021

Varied personal accounts of cannabis consumption causing a wide range of urinary effects have included but are not limited to: being unable to pee while feeling a strong urge to pee, peeing caused by laughter, and multiple sclerosis patients learning their cannabis medication also helps reduce the number of times they have to run to the bathroom.

Cannabinoids 86

Cannabinoids Consumption Patients Cannabis 86

WeedAdvisor

MAY 16, 2019

But despite the fact that veterans arguably are among the most deserving groups for this key treatment – considering what they saw and endured – bureaucratic red tape makes access difficult. Getting past that takes time and psychiatric treatment. WeedAdvisor’s Concern for Vulnerable Patients. . of suicides in the U.S.

Marijuana 49

Marijuana Treatment Access Sleep 49

Greencamp

FEBRUARY 2, 2019

Even though cannabis and cannabinoid-derived pharmaceuticals are both frequently used by HIV/AIDS patients, several studies show that something interesting happens when cannabis is consumed. Cannabis as a palliative aid for HIV patients. What is HIV and how is it manifested? How classical pharmaceuticals fight HIV.

Marijuana 110

Marijuana Therapy Cannabinoids Patients 110

CannaMD

OCTOBER 23, 2019

Medical conditions such as HIV/AIDS and cancer , and their related treatments, can also cause extreme nausea. As the study authors note: Enhancing endocannabinoid system signaling may represent an alternative therapeutic strategy for motion sickness in individuals who do not respond to currently available treatments.

Research and Development 61

Research and Development Marijuana Treatment Cannabinoids 61

Veriheal

OCTOBER 1, 2020

In 2004, cannabis was reclassified as a class C drug but was reinstated to Class B in 2008 following Prime Minister Gordon Brown’s decision to go against the advice offered up by the Advisory Council on the Misuse of Drugs. . A prescription for medical cannabis can be made once all other treatment options have been exhausted.

Legalization 104

Legalization Oil Medicine Media 104

Greencamp

AUGUST 16, 2018

Because of the very rapid progression of ALS in the majority of patients, understanding how cannabis could help in the alleviation of symptoms is incredibly important for ALS sufferers. Both upper and lower motor neurons suffer severe damage in ALS patients. As few as 10% of ALS patients live longer than 10 years after being diagnosed.

Strains 94

Strains Cannabinoids Research and Development Indica 94

Cannabis Law Report

JUNE 25, 2021

Nutt will lead Awakn’s neuroscience research of psychedelic compounds for treating a broad range of addictions where the consequences for the patient, their family, and society are at present most severe. Nutt’s existing role as Chair of Awakn’s Scientific Advisory Board, Prof.

Research and Development 66

Research and Development Therapy Medicine Pets 66

Cannabis Law Report

MAY 28, 2019

Many patients with PTSD report having flashbacks or intrusive thoughts which result in involuntarily re-living past traumatic events. 5] The most common treatments for PTSD are cognitive behavioral therapy or selective serotonin uptake inhibitors (SSRIs) including Paxil, Zoloft, and Prozac. [6] 2004), United States v.

Access 49

Access Marijuana Research and Development Programs 49

Cannabis Law Report

NOVEMBER 29, 2021

born and raised on the Pacific Island of Guam, was sworn in as Justice of the Supreme Court of Guam in 2004. This anniversary of recreational legalization is also a moment to reflect on decades of medical cannabis legalization and how we can do better for patients and improve safe and equitable access to their treatment.

Research and Development 52

Research and Development Topical Programs Business 52

Cannabis Law Report

AUGUST 6, 2019

patients in a non-medical marijuana use state from purchasing or using cannabis medication obtained in the neighboring medical marijuana “border state.” public school districts conducted random drug testing in at least one of their high schools during the 2004–2005 school year (Ringwalt et al. ” .

Marijuana 40

Marijuana Research and Development Programs Collective 40

The Cannigma

JANUARY 13, 2023

The fact that migraine is now ranked as the second leading cause of years lived with disability illustrates the magnitude of the negative impact of the disease to patients and their ability to function normally. A 2019 retrospective review of 316 patients found that medical cannabis improved the experience of 88.3%

Terpenes 132

Terpenes Strains THC Treatment 132

Project CBD

JULY 12, 2023

But increasingly, researchers, physicians, and patients are recognizing the value of cannabinoid acids as well as other compounds found in the raw cannabis plant, which contains various enzymes, vitamins, minerals, protein, fiber, essential fatty acids, flavonoids, carotenoids, terpenes, and other polyphenols. Cannabis roots. Callaway, J.

Cannabinoids 185

Cannabinoids Wellness and Beauty Trichome Cannabis 185

FloridaMarijuana.net

OCTOBER 6, 2018

More than ever, cannabis can aid in the treatment of chronic disease and as a supplement to a patient’s healthcare regime. As the cannabis plant, and medical marijuana, become more mainstream, science is proving what humans have known for centuries: cannabis is a means by which patients can seek and receive holistic wellness.

Terpenes 100

Terpenes Strains Oil Patients 100

The Cannigma

DECEMBER 7, 2021

The CWS diagnostic category was sparked by a 2004 study, led by Alan J. On the other end of the spectrum are patients labeled with cannabis use disorder (CUD) , or, as Dr. Peter Grinspoon puts it “persistent use of cannabis despite negative consequences.” Also a factor, comorbidity with mental or somatic disorders.

Sleep 111

Sleep Research and Development Treatment THC 111

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. It was also used as a topical treatment for haemorrhoids, ear infection, and wounds (Aldrich 1997 ; Touw 1981 ).

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

APRIL 8, 2022

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. On May 3, 2021, our study of MDMA-assisted therapy for PTSD achieved successful results for patients with severe, chronic PTSD.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Cannabis Law Report

OCTOBER 29, 2019

Pharmacokinetics, Safety, and Clinical Efficacy of Cannabidiol Treatment in Osteoarthritic Dogs. Dogs received each of two treatments: CBD oil (2 mg/kg) or placebo oil every 12 h. Each treatment lasted for 4 weeks with a 2-week washout period. Veterinary assessment showed decreased pain during CBD treatment ( p < 0.02).

Safety 45

Safety CBD Clinical Trials Oil 45

The Cannigma

OCTOBER 8, 2021

The United Kingdom legalized medical cannabis in November 2018 but the program is the subject of criticism regarding access to medicine and approval of patients. The UK government made the decision i n 2004 to reclassify cannabis from a Class B to Class C drug, but the decision was rescinded in 2009.

Legalization 52

Legalization Medicine Conditions Patients 52

Cannabis Law Report

JULY 12, 2019

Side effects were very prevalent in 79% of all patients taking a refined CBD product, some of which were severe like thrombocytopenia and transaminase elevations in the liver. Review: During an open-label trial of pure CBD with Lennox-Gastaut and Dravet patients, 79% of all patients reported side effects.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73